Ryaltris, which was developed by Glenmark, is a novel, fixed-dose combination nasal spray of an anti-histamine (olopatadine hydrochloride) and a steroid (mometasone furoate). Each unit of the ...

Indian pharma major Glenmark Pharmaceuticals Limited and Canadian pharmaceutical company SaNOtize Research & Development Corp, on Wednesday announced launch of nasal spray to treat adult Covid-19 ...

The first recall affects 45,504 bottles of Ryaltris (olopatadine hydrochloride and mometasone furoate) Nasal Spray. Glenmark Pharmaceuticals Inc., based in New Jersey and a subsidiary of the ...